1) Walker EA, Petscavage JM, Brian PL, Logie CI, Montini KM, Murphey MD. Imaging features of superficial and deep fibromatoses in the adult population. Sarcoma. 2012, 2012.
2) Weiss SW, Goldblum JR, Enzinger FM. Fibromatoses. In Enzinger and Weiss’ Soft Tissue Tumors, pp. 227–228, Mosby Elsevier, Philadelphia, USA, 2008.
3) Ledderhose G. Über zerreisungen der plantarfascie. Arch Klin Chir. 48:853-6, 1894.
4) Espert M, Anderson MR, Baumhauer JF. Current concepts review: plantar fibromatosis. Foot & ankle international. 39(6):751-7, 2018.
5) Kiter E, Celikbas E, Akkaya S, Demirkan F, Kilic BA. Comparison of injection modalities in the treatment of plantar heel pain: a randomized controlled trial. Journal of the American Podiatric Medical Association. 96(4):293-6, 2016.
6) Ketchum LD, Donahue TK. The injection of nodules of Dupuytren’s disease with triamcinolone acetonide. J Hand Surg Am. 25(6):1157-1162, 2000.
7) Aluisio FV, Mair SD, Hall RL. Plantar fibromatosis: treatment of primary and recurrent lesions and factors associated with recurrence. Foot & ankle international. Nov;17(11):672-8, 1996.
8) Pentland AP, Anderson TF. Plantar fibromatosis responds to intralesional steroids. Journal of the American Academy of Dermatology. 12(1):212-4, 1985.
9) Neagu TP, Ţigliş MI, Popescu A, Enache V, Popescu ŞA, Lascăr IO. Clinical, histological and therapeutic modern approach of Ledderhose disease. Rom J Morphol Embryol. 59(3):691-7, 2018.
10) Meek RM, McLellan S, Reilly J, Crossan JF. The effect of steroids on Dupuytren's disease: role of programmed cell death. The Journal of Hand Surgery: British & European Volume. 27(3):270-3, 2002.
11) Ketchum LD, Smith J, Robinson DW, Masters FW. The treatment of hypertrophic scar, keloid and scar contracture by triamcinolone acetonide. Plastic and Reconstructive Surgery. 38(3):209-18, 1966
12) Ketchum LD, Donahue TK. The injection of nodules of Dupuytren's disease with triamcinolone acetonide. The Journal of hand surgery. 25(6):1157-62, 2000.
13) Pruce AM, Miller Jr JA, Berger IR. Anatomic landmarks in joint paracentesis. In Clinical symposia (Summit, NJ: 1957) 16, p. 19, 1964.
14) Altay T, Günal I, Öztürk H. Local injection treatment for lateral epicondylitis. Clinical Orthopaedics and Related Research. 398:127-30, 2002.
15) Sammarco GJ, Mangone PG. Classification and treatment of plantar fibromatosis. Foot & ankle international. 21(7):563-9, 2000.
16) Luck JV. Dupuytren's contracture: a new concept of the pathogenesis correlated with surgical management. JBJS. 41(4):635-64, 1959.
17) Downey MS. Point-Counterpoint: Is Conservative Care The Best Approach For Plantar Fibromatosis? Podiatry Today. 26(2):36-42, 2013
18) Meek RM, McLellan S, Crossan JF. Dupuytren’s disease: a model for the mechanism of fibrosis and its modulation by steroids. The Journal of bone and joint surgery. British volume. 81(4):732-8, 1999.
19) Perez-Castro R, Patel S, Garavito-Aguilar ZV, Rosenberg A, Recio-Pinto E, Zhang J, Blanck TJ, Xu F. Cytotoxicity of local anesthetics in human neuronal cells. Anesthesia & Analgesia. 108(3):997-1007, 2009.
20) Li Z, Xia C, Yu A, Qi B. Ultrasound-versus palpation-guided injection of corticosteroid for plantar fasciitis: a meta-analysis. PLoS One. 21;9(3):e92671, 2014.
21) Ledderhose Disease. National Center for Advancing Translational Sciences – Genetic and Rare Diseases Information Center. Website. March 2018. Available at: https://rarediseases.info.nih.gov/diseases/6873/ledderhose-disease. Accessed July 4th, 2020.
22) Bakotic BW, Borkowski P. Primary soft-tissue neoplasms of the foot: the clinicopathologic features of 401 cases. The Journal of foot and ankle surgery. 40(1):28-35, 2001.